We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Reeder, M, Dougherty, J, White, LJ.Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med1993;22(10):1593–6.Google Scholar
2
2.Girard, DE.The relationship between physicians in training and pharmaceutical companies: A time for guidelines?Arch Intern Med1992;152(5):920–1.CrossRefGoogle ScholarPubMed
3
3.Rosner, F.Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines. Mt Sinai J Med1995;62(6):427–30.Google ScholarPubMed
4
4.Wazana, A.Physicians and the pharmaceutical industry: Is a gift ever just a gift?JAMA2000;283(3):373–80.CrossRefGoogle ScholarPubMed
6.Ryan, TJ, Anderson, JL, Antman, EM, Braniff, BA, Brooks, NH, Califf, RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol1996;28(5): 1328–428.Google Scholar
7
7.Spingarn, RW, Berlin, JA, Strom, BL.When pharmaceutical manufacturers’ employees present grand rounds, what do residents remember?Acad Med1996;71(1):86–8.CrossRefGoogle ScholarPubMed